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ABSTRACT 
 
Background: Sub-Saharan Africa is representing 69 % of the global HIV burden, with an 
estimated number of 34 million HIV positive people worldwide, 1.2 million HIV positives  
are living in Zimbabwe. With around one in seven adults living with HIV today, 
Zimbabwe is experiencing one of the most severe HIV/AIDS epidemics in the world. In 
2010, more than 13 % of the population in Zimbabwe was younger than 5 years, and 
according to UNICEF, as many as one in four children in Zimbabwe are orphaned as a 
result of parents dying from HIV/AIDS. 
 
We wanted to study the growth among a group of infants related to maternal HIV-status in 
the Harare region during 2002-2003 related to the WHO growth charts.  
 
Method: Our study is based on a broader prospective cohort study about mother to child 
transmission (MTCT) of HIV in Harare, lasting from April 2002 to November 2003. A 
total of 1050 pregnant women were enrolled at gestational age 36 from three clinics 
outside Harare. 774 (408 HIV negative mothers and 366 HIV positive mothers) met our 
criteria of inclusion. They were followed up with their index child, and measurements of 
weight, length and head circumference were taken at birth, 6 weeks, 4 months and 9 
months of age. Data on boys and girls were analysed separately. The sample size for the 
boys and girls who had their measurements registered at all time points were 122 and 122 
for weight, 116 and 122 for length, and 120 and 124 for head circumference respectively. 
 
Results:. The differences we found in growth according to maternal HIV-status at the 
different time points, were of no statistical significance (p>0.05). Neither did we find any 
significant differences in low birth weight (< 2500 g) in the two groups We also compared 
the growth curves to WHO´s growth standards, to see how many of the children who fell 
beneath the 3
rd
 percentile and above the 97
th
 percentile. We found that the mean for length 
lies lower and the mean for head circumference lies higher for the infants in the study, in 
comparison to the WHO growth standards. 
According to maternal HIV-status, we found that there were almost fifteen times more 
deceased mothers and more than three times more deceased infants in the HIV-positive 
group. Amittedly, all the children who died before 9 months of age are not included in our 
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growth analysis, and may have influenced the results in the HIV positive group in a 
negative favour.  
Conclusion: In our study results we found no differences in growth of statistical 
significance according to maternal HIV-status the first 9 months of life. What we did find, 
was that HIV positive mothers had a higher mortality and so did their children. 
The findings in our study might be unreliable due to several possible sources of bias, with 
measurement errors being one of these. Since it is likely to believe that these errors were 
equally divided in both groups, we still believe that our results are to be considered as 
valuable. Similar studies in other African countries show variable results, and further 
research is needed to conclude that there is no difference in growth according to maternal 
HIV-status. 
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ACRONYMS 
 
AIDS: Acquired Immunodeficiency Syndrome 
ANC: Antenatal Care 
ART: Anti-retroviral therapy 
ARV: Antiretroviral 
BHAMC: Better Health for African Mother and Child 
CDC: The Centers for Disease Control and Prevention 
HDI: Human Development Index 
HIV: Human Immunodeficiency Virus 
MGRS: Multicentre Growth Reference Study  
MTCT: Mother To Child Transmission 
PEPFAR: US President´s Emergency Plan for AIDS Relief 
PMTCT: Prevention of Mother To Child Transmission 
STI: Sexually Transmitted Infections 
UNICEF: United Nations International Children´s Emergency Fund 
USD: United States Dollar 
WHO: World Health Organization 
ZANU: Zimbabwe African National Union 
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1.0 INTRODUCTION 
 
1.1 Problem statement  
 
The HIV pandemic has been and is still a big global health challenge. Zimbabwe has been one 
of the most affected countries, which is why we wanted 
 to do our project there. When choosing the topic for our thesis, we wanted to focus on HIV 
and child health because of its impact on the global future. Three of the United Nations 
Millennium Development Goals are related to this: reduce child mortality, improve maternal 
health and combat HIV/AIDS. (1)  
 
The topic we chose within HIV and child health was infant growth. We wanted to learn if 
there were any differences in growth patterns in infants born by HIV-positive mothers 
compared to infants born by HIV-negative mothers in Harare, with focus on development in 
weight, length and head circumference. In relation to that we also wanted to see how other 
factors were divided in the two groups, like breastfeeding patterns, because of its big impact 
on child growth.  
 
1.2 About Zimbabwe 
 
The Republic of Zimbabwe is landlocked in the south-east of Africa, bounded by South 
Africa in the south, Botswana in the south-west, Zambia in the north-west and Mozambique 
in the north and the east. (2) It is the 59
th
 largest country in the world, a below-average size 
for Africa, and covers 390 580 square kilometres. It lies on an extensive inland plateau 900 
meters or more above sea level. (3)  
 
Zimbabwe is a country with many resources, including minerals and a good climate for varied 
agriculture. Tobacco, gold and cotton have been the most important export products. Other 
important productions are corn, wheat, sugar, peanuts, soybeans, tea, coffee, meat, fish, 
flowers, fruits and vegetables. The political unrest has unfortunately had a negative impact on 
the tourist industry. (4) 
According to WHO, the estimated total population in Zimbabwe in 2010 was 12 571 000. (5) 
Other numbers from 2010 are: population under 18 years: 5 866 000 and population under 5 
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years: 1 692 000. (6) From these statistics, 46.7 % of the total population was younger than 18 
years old and 13.5 % younger than 5 years old.  
The HDI for Zimbabwe has fallen from a rank of 130
th
 in 1999 to 151
th
 in 2007 out of 177 
countries (7), and was in 2011 ranked number 173 out of 187 countries. (8)  
 
Figure 1: Map of Zimbabwe                      Figure 2: Map of Africa  
        
 
1.3 Zimbabwe and healthcare 
 
Throughout Zimbabwe´s 10 provinces, there are 126 mission hospitals and clinics. There have 
been an increasing number of patients from Harare to the rural mission hospitals after the 
closure of public hospitals in Harare in 2008. (7)  
The new State of Zimbabwe became legally independent in April 1980, the same year as 
Robert Mugabe became Prime Minister (later President) and leader of the ZANU-PF 
government. (3) The government’s actions have markedly worsened the collapse of the 
healthcare system. The lives of most Zimbabweans improved dramatically in the first years of 
independence, due to significant economic and social progress. The healthcare system in 
Zimbabwe was so good in the 1990s that 85 % of the population lived within 10 km of a 
health facility. (7) Unfortunately, due to Mugabe´s economic policies, the 1990s featured a 
number of strikes, and in 1997 a national strike paralyzed the country. (3)  
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Zimbabwe experienced an economic collapse, which again led to a sharp rise in 
unemployment, food insecurity and malnutrition because of a dramatically fall in agricultural 
production, destruction of the public healthcare and outbreaks of infectious diseases. The 
public health system collapse hit the public hospitals and clinics, the most basic state 
functions in protecting the health of the population. As late as in 2008, there were no intensive 
care unit and no functioning critical care beds in the public sector. Most wards and surgical 
suits gradually closed, and paediatric surgeries ceased between September and November 
2008. The closure of hospitals also affected the medical students, and for a period the medical 
school closed. Private sector user fees for medical services were way more expensive than the 
majority of the population could afford: 3000 USD for a Caesarean section, 500 USD to 
secure a bed and 200 USD in cash for a medical consultation. As a consequence of this, the 
whole population but the wealthiest Zimbabweans were denied access to medical help. (7) 
The crisis also led to a collapse in the water delivery systems, contamination of surface water, 
loss of water supply through leakage from broken water pipes and clogged sewerage pipes 
leading to non-functional toilets. To manipulate elections, the Mugabe government 
established severe food restrictions during election periods from 2000 persisting until 2008. In 
2008, all actions of charitable organizations were stopped, and international humanitarian 
organizations were prevented from delivering food aid. The food insecurity also had an 
impact on the HIV/AIDS epidemic, with an increase in commercial sex. Many women 
considered prostitution to be the last and best opportunity to earn money to buy food to their 
families. The HIV-infected part of the population were especially vulnerable to the food and 
water crisis, because of their impaired immune system and increased risk of other infections, 
weight loss and diarrhoea. (7) 
The diminished access to care, public hospital closings and inadequate or unaffordable 
medical supplies, led to a drastic fall in vital statistics; including increased maternal, adult and 
infant mortality, cholera epidemics, and worsening of HIV/AIDS, tuberculosis, malnutrition 
and vitamin deficiency. (7)   
The life expectancy at birth also fell dramatically. Life expectancy at birth (mean age both 
sexes): 55 years (1970), 61 years (1990), 36 years (2006), 50 years (2010). (6) 
 
In addition, there has been lack of access to essential medications and medical supplies, 
including the access to HIV/AIDS care and treatment. Since 2006, different HIV/AIDS donor 
programs like the PEPFAR program, the Global Fund to Fight AIDS, Tuberculosis and 
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Malaria and the CDC, have been affected by the same political control, which has affected the 
healthcare in Zimbabwe. (7)  
1.4 Zimbabwe and HIV 
 
Zimbabwe has had severe HIV/AIDS and tuberculosis epidemics for more than two decades. 
In 1999, UNAIDS considered Zimbabwe to be the highest prevalence country for HIV 
infection worldwide, with one in four of all adults HIV positive. (7) 
The most detrimental effect on Zimbabwe´s dwindling population has probably been the 
prevalence of HIV/AIDS. With around one in seven adults living with HIV today, Zimbabwe 
is experiencing one of the most severe HIV/AIDS epidemics in the world. (3)  
 
According to UNAIDS World AIDS Day Report (2012), an estimated number of 34 million 
people are HIV positive globally. The majority of new HIV infections occur in Sub-Saharan 
Africa, and counts for 23.5 million of the total number. In other words, Sub-Saharan Africa is 
representing 69 % of the global HIV burden. Out of these, 1.2 million are living in Zimbabwe. 
Most countries in Southern Africa have a high HIV prevalence, but the incidence has been 
dramatically reduced the last decade. Between 2001 and 2011, the rate of new HIV infections 
among adults (15-49 years) dropped by 50 % in Zimbabwe. Between 2005 and 2011, Sub-
Saharan Africa has cut the number of people dying of AIDS-related causes by 32 %, nearly 
90 000 fewer deaths in Zimbabwe. (9) 
 
The notable decline in HIV prevalence has been attributed to both high mortality and a 
decline in HIV incidence. (10) The decline in HIV incidence is a result of safer sexual 
behaviours (including increased condom use, reduced number of sexual partners, later sexual 
debut and more information about HIV), and an increasing number of people accessing 
treatment with ARV drugs. In some countries though, the prevalence has increased instead of 
stabilizing or declining, due to increased survival of infected people due to treatment. (11) In 
2004, the U.S. funded PEPFAR program began providing support for ART. Before 2004, 
HIV/AIDS treatment was largely unavailable in Zimbabwe. (7) According to CDC, the 
reported number of people receiving ART in Zimbabwe in February 2010, was 218 589. The 
estimated number of people needing ART was 640 000. (12)   
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Zimbabwe has an enormous number of AIDS orphans, children who have lost one or both 
parents to AIDS. Zimbabwe has a higher percentage of orphans than any other country in the 
world. According to UNICEF, as many as one in four children in Zimbabwe are orphaned as a 
result of parents dying from HIV/AIDS. (3) 
 
Estimated number of children who have lost their mother, father or both parents to AIDS, and 
who were alive and under age 17: 720 000 (2001). (13) 
 
Estimated number of children and adults living with HIV. (25) 
Population 2001 2002 2003 
Estimated children (0-14)  210 000 220 000 230 000 
Estimated adults (15+)  1 600 000 1 500 000 1 400 000 
Estimated women (15+) 880 000 850 000 800 000 
 
Estimated HIV prevalence (%) among adults (age 15-49) in 2001 was 26%, however in the 
last decade the prevalence has decreased to almost the half. (6), (13) 
 
1.5 Paediatric HIV and mother-to-child transmission 
 
In 2011, 330 000 infants were newly infected with HIV globally, a 43% decline since 2003 
and 24% decline since 2009. The primary cause of this reduction is the focus on ARV- and 
infant feeding-based prevention services. Coverage of effective ARV regimens for preventing 
MTCT of HIV, reached 57% in low- and middle-income countries the same year. Even 
though access to treatment and care in developing countries are expanding, only 28% of 
children in need received ART in 2011, compared to 58% for adults. (14) 
 
Transmission rate for HIV has been reported to range from 14% to 64%, with a higher rate in 
Africa compared to Europe and North America. This reflects a higher prevalence of risk 
factors in African women. (15) More than 95% of HIV infected children acquired the virus 
due to vertical transmission. In absence of ART, the transmission rate varies from 20% to 
30%. Vertical transmission can happen at any time during the perinatal period from early 
gestation, delivery and postnatal period through breastfeeding. When it comes to the perinatal 
transmission, most (50% to 80%) are believed to occur near or during delivery. (16)  
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Risk factors for MTCT can be divided into maternal and obstetric: 
1. Maternal risk factors: , increased viral load, anaemia, low maternal CD4+ lymphocyte 
count, frequency of intercourse during pregnancy, multiple sexual partners, and 
presence of other sexually transmitted diseases, cigarette smoking and illicit drug use 
(17) 
2. Obstetric risk factors: prolonged rupture of amniotic membranes, mode of delivery 
(elective C-section as protective), birth order in twin gestation, placental disruption or 
inflammation and obstetric complications. (17) 
 
1.6 Growth in infants 
 
The extra uterine growth happens in three stages: infancy, childhood and puberty. Infancy 
growth begins with a rapid growth, especially seen on the weight curves. Children with 
growth retardations at delivery, have a catch-up-growth the first months. After the first year of 
living, the growth seems to slow down. The biggest influence on growth the first year of life 
is the infant’s nutritional status, while growth hormones have less impact. A child with lack of 
growth hormone can have an almost normal growth chart in this period. (18) 
 
The term failure to thrive is commonly used for children who grow less than expected over a 
time period. The ethology can be multifactorial, with chronic infection being one of the 
possible causes along with other psychosocial, environmental, nutritional, endocrine and 
metabolic factors. (18)  
 
Changes in height, weight, and head circumference are used as indicators for normal and 
pathologic growth. These are compared with established standards for a given population at a 
given age in a growth chart. When evaluating a child’s growth, one must consider its genetic 
potential. Growth velocity, the change in growth over time, is a more sensitive index of 
growth than a single measurement. (19)  
 
When comparing growth in the infants in our study, we have used WHOs child growth 
standards for growth velocity, based on weight, length and head circumference. These 
standards are made after the WHO MGRS from 1997 to 2003 in USA, Oman, Norway, 
Brazil, Ghana and India. A total of 1737 children (894 boys and 843 girls) were followed 
from birth to 24 months in a longitudinal study component in the MGRS. (20)  
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1.7 WHO guidelines on HIV and infant feeding 
 
The newest WHO guidelines on HIV and infant feeding are from 2010. Principles used 
making these guidelines include not only reducing MTCT of HIV, but also balancing HIV 
prevention with other causes of child morbidity and mortality, while meeting the nutritional 
requirements. The focus is thus now on securing a HIV free survival of the child. Every 
nation should decide which of these two strategies to use: (21) 
1. Breastfeed and receive full ARV intervention.  
2. Avoid all breastfeeding (most likely to give the child an HIV-free survival). 
 
Decision should be made considering the socio-economic and cultural contexts, availability 
and quality of health services, local epidemiology and main cause of maternal and child 
undernutrition and infant and child mortality. In many of the developing countries, the most 
important causes of child morbidity and mortality are malnutrition and other diseases such as 
diarrhoea. (21) 
 
When the national strategy is breastfeeding and full ARV intervention, recommendations are 
following: (21) 
- Mothers known to be HIV-infected should exclusively breastfeed the first six months, 
and thereafter introduce appropriate complementary foods while continuing 
breastfeeding the twelve first months of life.   
- Breastfeeding should only stop once a nutritionally adequate and safe diet without 
breast milk can be provided. 
 
And what happens when this strategy is chosen, but ARVs are unavailable? (21)  
- Even in these conditions mothers should be counselled to exclusively breastfeed in the 
first six months of life and continue breastfeeding thereafter, unless environmental 
and social circumstances are safe for, and supportive of, replacement feeding.  
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2.0 METHOD 
 
BHAMC is the name of a project started in 2002, as a study of national PMTCT of HIV and 
other STIs. The project is a cooperation between Universities in Zimbabwe, Tanzania and 
Norway. (26) 
 
A standardised questionnaire to determine demographic, socioeconomic, obstetric history, 
sexual behaviour and life styles was used in an interview with all the women participating. 
Biological samples were collected to screen for STIs, including HIV infection. Infant 
anthropometrical measurements were taken at each scheduled visit (birth, 6 weeks, 4 months 
and 9 months). (27) Weight-for-length charts are commonly used in paediatrics, but because 
of uncertain measurements of length of the infants in our study, we chose to use the single 
measurements of weight and length.  
 
2.1 Study area and population 
 
This study took place in Harare, the capital city of Zimbabwe. Harare is geographically placed 
in Mashonaland, north-east in Zimbabwe, and has a population of approximately 1.6 million 
(in 2006). Zimbabwe’s largest ethnic group, the Shona people, have their cultural centre in the 
capital. (22)  
 
Three peri urban clinics were included in the study: St. Marys Clinic, Seke North Makoni and 
Epworth. These clinics offer maternal and child health services. St. Marys Clinic and Seke 
North Makoni fall under Chitungwiza municipality, approximately 30 km south of Harare, 
with a population of 321 782 in 2002 (23). Chitungwiza was earlier a part of Harare, but is 
now an independent city. (22) Epworth lies in a peri urban residential area called 
Mashonaland East Province, situated 12 km south-east of Harare, with a population of 1.1 
million in 2002 (24). A total of 1050 pregnant women were enrolled from these three clinics, 
and were followed with their newborns after delivery.   
 
2.2 Study design 
 
Our study is using data from the BHAMC: a prospective cohort study about MTCT of HIV in 
Harare, lasting from April 2002 to November 2003. HIV positive and negative pregnant 
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women were enrolled at gestational week 36, after being pre- and post-test counselled for 
HIV infection as part of the National program on PMTCT. (27) Mothers and their infants 
were initially followed up from birth, 6 weeks, 4 months and 9 months of age, and every 6 
months thereafter until 5 years of age. 
 
In August 2011, we spent four weeks in Harare to collect the material from this study for our 
project. The data was already sorted in individual files for each couple of mother and child, a 
total of 1050 files. We went through data from all of these files and used follow-up 
information about the mother and the children until 9 months of age. 
 
2.3 Criteria for inclusion 
 
To be included, these criteria had to be recorded: 
1. HIV status of the mother  
2. HIV status of the infant 
3. Weight, length and head circumference at birth of the infant 
4. Gender of the infant  
 
We went through 1050 files in total, and out of these, 774 (408 HIV negative mothers and 366 
HIV positive mothers) met our criteria of inclusion. The variables we chose to use and collect 
were following:  
1. Age mother 
2. Education level 
3. Marital status 
4. HIV-status of mother  
5. HIV-status of infant 
6. Gender of infant 
7. Weight, length and head circumference at birth, 6 weeks, 4 months and 9 months 
of age 
8. Deceased mothers 
9. Deceased infants 
10. Breastfeeding or not 
11. Summary of clinic visits with infant after birth 
 
 15 
2.4 Data analysis plan  
 
We looked at girls and boys separately, because of the known differences in growth between 
them, with boys having a higher weight, length and head circumference in general. When 
analysing, we first found the mean values for weight, length and head circumference at birth, 
6 weeks, 4 months and 9 months for all registered data. Then we did the same, but only of 
those children who had their recordings at all the time points for each parameter, meaning that 
they for example had to have their weight registered at birth, 6 weeks, 4 months and 9 
months. Therefore we missed out the deceased children; one stillbirth, two died before 6 
weeks, 14 before 4 months and 29 before 9 months of age. This gave us a selected group, and 
the groups were different for weight, length and head circumference. In both of these study 
groups, we found no difference in mean values for growth that was of statistically 
significance, between children of HIV negative and HIV positive mothers. In our results, we 
have therefor decided to use the analyses from our selected study group.  
 
Our statistical analysis were done using SPSS statistical software version 20.0 for Macintosh. 
An independent-samples t-test was used to compare growth means between children of HIV 
negative and HIV positive mothers. The significance level was set to p < 0,05 and a 95% 
confidence interval was used to measure the strength of association between a potential effect. 
We also used SPSS to do frequency tests, crosstabs and chi-square test for other factors such 
as maternal age, education level, marital status, breastfeeding, infant follow up visits and 
deceased mothers and infants, to see if there were any differences according to maternal HIV- 
status.  
 
Growth curves for comparing growth in the two groups and to WHO growth standards, were 
made using Microsoft Excel for Mac 2011, version 14.2.4.  
 
2.5 Ethical clearance 
 
The Medical Research Council of Zimbabwe and the Ethical Committee in Norway have 
given the ethical clearance for BHAMC.  
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3.0 RESULTS 
The records of children born to 774 mothers (408 HIV negative and 366 HIV positive) were 
investigated. Only children where the growth parameters were recorded during the first 9 
months of life were included. 
 
Analyses were done separately for boys and girls. The number of boys and girls who had their 
weight registered at all time points were 122 and 122 respectively (table 1), for length 116 
and 122 respectively (table 2) and for head circumference 120 and 124 respectively (table 3). 
 
3.1 Weight 
 
 Table 1: Weight of boys and girls according to maternal HIV-status 
  Maternal 
HIV status 
N Mean 
weight (kg) 
SD p-value 95% CI 
lower 
95% CI 
upper 
 
 
B   
O   
Y   
 S 
Birth Neg 
Pos 
52 
70 
3,14 
3,05 
0,38 
0,48 
0,27 
 
-0,07 0,25 
6 weeks Neg 
Pos 
52 
70 
4,90 
4,71 
0,61 
0,80 
0,14 -0,07 0,44 
4 months Neg 
Pos 
52 
70 
7,49 
7,29 
1,14 
1,34 
0,39 
 
-0,26 0,66 
9 months Neg 
Pos 
52 
70 
9,09 
8,98 
1,55 
1,58 
0,71 -0,46 0,68 
 
 
G  
I 
R 
L 
S 
Birth Neg 
Pos 
59 
63 
3,04 
3,03 
0,36 
0,50 
0,86 -0,14 0,17 
6 weeks Neg 
Pos 
59 
63 
4,49 
4,45 
0,66 
0,61 
0,70 -0,18 
 
0,27 
4 months Neg 
Pos 
59 
63 
6,74 
6,61 
1,30 
1,24 
0,58 -0,33 0,58 
9 months Neg 
Pos 
59 
63 
8,51 
8,32 
1,39 
1,50 
0,46 -0,33 0,71 
 
Table 1 shows that the boys and girls born of HIV negative mothers (n = 52, n = 59) had a 
tendency to higher mean weight at all time points, compared to those born of HIV positive 
mothers (n = 70, n = 63), but not statistically significant (p > 0,05). As expected the boys had 
å higher mean weight at all time points.  
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3.2 Length 
 
Table 2: Length of boys and girls according to maternal HIV-status 
 
 
Maternal 
HIV status 
N Mean length 
(cm) 
SD p-value 95% CI 
lower 
95% CI 
upper 
 
 
B 
O 
Y 
S 
Birth Neg 
Pos 
50 
66 
49,5 
48,7 
2,59 
3,72 
0,22 -0,45 1,99 
6 weeks      Neg 
Pos 
50 
66 
54,2 
55,4 
5,35 
4,76 
0,19 -3,10 0,63 
4 months Neg 
Pos 
50 
66 
62,3 
61,3 
4,69 
4,99 
0,26 -0,78 2,83 
9 months Neg 
Pos 
50 
66 
68,5 
68,8 
5,65 
5,27 
0,77 -2,32 1,72 
 
 
G 
I 
R 
L 
S 
Birth Neg 
Pos 
60 
62 
48,7 
47,7 
2,62 
3,62 
0,11 -0,21 2,06 
6 weeks Neg 
Pos 
60 
62 
54,8 
54,4 
3,51 
4,90 
0,66 -1,19 1,87 
4 months Neg 
Pos 
60 
62 
60,7 
60,7 
5,08 
5,46 
0,99 -1,90 1,88 
9 months Neg 
Pos 
60 
62 
67,5 
65,5 
5,00 
6,35 
0,05 -0,01 4,09 
 
Table 2 shows that the boys born of HIV negative mothers (n = 50) had a tendency to higher 
mean length at birth and 4 months, while boys born of HIV positive mothers (n = 66) had 
tendency to higher mean length at 6 weeks and 9 months. The girls born of HIV negative 
mothers (n = 60) had tendency to higher mean length at birth, 6 weeks and 9 months. None of 
these differences however, were statistically significant (p > 0,05). 
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3.3 Head circumference 
 
Table 3: Head circumference of boys and girls according to maternal HIV-status 
 
 
Maternal 
HIV status 
 
N 
Mean head 
circumference 
(cm) 
 
SD 
 
p-value 
95% 
CI 
lower 
95%  
CI 
upper 
 
 
B 
O 
Y 
S 
Birth Neg 
Pos 
52 
68 
34,5 
34,3 
1,77 
2,62 
0,65 -0,65 1,03 
6 weeks Neg 
Pos 
52 
68 
38,6 
39,8 
2,73 
5,23 
0,16 -2,71 0,45 
4 months Neg 
Pos 
52 
68 
43,6 
43,7 
3,15 
4,30 
0,88 -1,51 1,29 
9 months Neg 
Pos 
52 
68 
46,7 
45,6 
3,78 
2,53 
0,05 -0,01 2,27 
 
 
G  
I 
R 
L 
S 
Birth Neg 
Pos 
62 
62 
34,2 
34,1 
1,27 
2,74 
0,07 -0,70 0,83 
6 weeks Neg 
Pos 
62 
62 
38,1 
38,7 
2,28 
2,20 
0,17 -1,36 0,24 
4 months Neg 
Pos 
62 
62 
43,5 
42,0 
4,94 
2,94 
0,04 0,08 2,97 
9 months Neg 
Pos 
62 
62 
45,1 
45,6 
2,88 
5,28 
0,45 -2,09 0,93 
 
Table 3 shows that boys born of HIV negative mothers (n = 52) had a tendency to higher 
mean head circumference at birth and 9 months, while girls born of HIV negative mothers (n 
= 62) had a tendency to higher mean head circumference at birth and 4 months. The 
differences however, were statistically significant only for the girls at the age of 4 months (p 
< 0,05), but these differences disappeared at 9 months of age (p > 0,05).  
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3.4 Growth curves according to maternal HIV-status and WHO´s growth standards 
 
                          BOYS                                                                             GIRLS 
  
Curve 1: Weight of boys and girls according to maternal HIV status and WHO growth standard  
 
 
                          BOYS                                                                   GIRLS 
  
Curve 2: Length of boys and girls according to maternal HIV status and WHO growth standards 
 
                              BOYS                                                                                      GIRLS 
  
Curve 3: Head circumference of infants according to maternal HIV status and WHO growth standards     
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3.5 Comparing growth percentiles with WHO´s growth standards 
 
Previous comparing of weight, length and head circumference has shown no difference in the 
infants according to maternal HIV-status. In this part we have therefor decided to look at the 
group as one, and find out how many of the children fell beneath the 3
rd
 percentile and above 
the 97
th
 percentile for WHO´s growth standards. 
 
Table 4: Percentage of infants who are beneath the 3
rd
 and above the 97
th
 percentile for 
WHO´s growth standards 
 
 
  
Weight  
(Nboys = 122, Ngirls = 122) 
Length  
(Nboys = 116, Ngirls = 122) 
Head circumference  
(Nboys = 120, Ngirls =124) 
< 3
rd
 
percentile 
(%) 
> 97
th
 
percentile 
(%) 
< 3
rd
 
percentile 
(%) 
> 97
th
 
percentile 
(%) 
< 3
rd
 
percentile 
(%) 
> 97
th
 
percentile 
(%) 
   
B 
O 
Y 
S 
Birth 4.9 0.8 15.5 6.9 16.7 9.2 
6 weeks 7.4 0.0 22.4 12.9 5.0 18.3 
4 months 6.6 13.1 20.7 6.9 0.8 40.8 
9 months 13.1 11.5 36.2 6.0 5.0 21.7 
G 
I 
R 
L 
S 
Birth 2.5 0.8 12.3 4.9 4.0 5.6 
6 weeks 4.0 3.3 22.1 15.6 0.8 23.4 
4 months 9.0 6.6 15.6 7.4 1.6 23.4 
9 months 4.9 6.6 37.7 9.0 6.5 27.4 
 
Table 4 shows that a lot of the boys and girls fell either beneath the 3
rd
 percentiles or above 
the 97
th
 percentile for WHO´s growth standards. This is highly expressed especially for 
length, where 12.3% to 37.7% is beneath the 3
rd
 percentile, and for head circumference, 
where 5.6 to 40.8% is above the 97
th
 percentile at any time point. These differences are also 
reflected in the mean measurements in curve 2 and 3, showing that the mean for length lies 
lower and the mean for head circumference lies higher for the infants in comparison to the 
WHO growth standards. However it looks like the differences are less at birth. The 
differences for the weight percentiles are less expressed. 
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3.6 Low birth weight 
 
Low birth weight is defined as weight at birth < 2500 g.  (28) One of the criteria for inclusion 
was that all children should have registered their birth weight. When comparing low birth 
weight according to maternal HIV-status, we therefor used all 774 pairs of mothers and 
children. We have not separated between boys and girls in this part.  
 
Table 5: Low birth weight (< 2500 g) of infants according to maternal HIV-status  
 
 HIV negative HIV positive 
 < 2500 g > 2500 g < 2500 g > 2500 g 
N 
 
37 371 45 321 
Percentage 
(%) 
9.1 90.9 12.3 87.7 
 
 
Table 5 shows that 12.3% of the children born of HIV positive mothers had a low birth 
weight. That is 3.2% more then the children born of HIV positive mothers, but our analysis 
show that this difference is not significant with a p-value = 0,145.   
 
 
3.7 Other factors 
 
When comparing other factors according to maternal HIV-status, we have used all data 
available in our study group of 774 pairs of mothers and children. Not all the information was 
available for all pairs.  
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Table 6: Others factors according to maternal HIV-status 
 
   
HIV negative 
 
 
HIV positive 
 
N 
 
% 
 
N 
 
% 
Age < 20 years 
> 20 years 
127 
280 
31.2 
68.8 
51 
315 
13.9 
86.1 
Education < 7 years 
> 7 years 
75 
333 
18.4 
81.6 
81 
285 
22.1 
77.9 
Marital 
status 
Living alone 
Cohabiting 
Married 
22 
8 
376 
5.4 
2.0 
92.6 
34 
6 
315 
9.6 
1.7            
88.7 
Breastfeeding 6 weeks 
4 months 
9 months 
309 
192 
177 
96.6 
98.5 
83.9 
269 
198 
117 
90.0 
83.5 
58.5 
Follow-up 
visits with 
infant 
< 3 visits  
> 3 visits 
193 
215 
47.3 
52.7 
171 
195 
46.7 
53.3 
Deceased 
mothers 
No 
Yes 
407 
1 
99.8 
0.2 
355 
11 
97.0 
3.0 
Deceased 
infants 
No  
Yes 
396 
12 
97.1 
2.9 
332 
34 
90.7 
9.3 
 
 
HIV positive mothers were older (p = 0,00), had less education (though not significant, p = 
0,18) and were more often single mothers (p = 0,02) compared with the HIV negative one.  
Fifteen times as many mothers in the HIV group had died (3.0 % versus 0.2%), a significant 
difference (p = 0,002). More than half of the children were having more than 3 follow-up 
visits in both groups.  
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A higher percentage of mothers were breastfeeding at all time points in the HIV negative 
group (p = 0,00) compared to the HIV positive group. A difference increasing from 6.6% 6 
weeks postpartum to 25.4% 9 months postpartum.   
 
There were 6.4% more deceased infants in the HIV positive group (p = 0,00); three times 
more compared to the HIV negative group.  
 
 
4.0 DISCUSSION  
We investigated 774 infants born to HIV positive and negative mothers. Surprisingly we 
found no significant difference between the two groups. In the following discussion we 
will focus upon bias in our method and results.  
 
4.1 Method 
 
Sources of bias   
 
- Selection of our study group: The original study had a total of 1050 participating 
women. The total numbers of excluded files were 276, representing 26,3 % of the 
total group. This could represent a selection bias leading to an unreliable result.  
There can be many sources of bias when one compares those who were willing to 
participate in the study from the beginning, versus those who did not.  
1) The participating women may have had another health-seeking behaviour:  
been more conscious about attending the follow-up visits, been more conscious 
about their own and the baby´s health, had more knowledge and a different 
understanding of the importance of follow-up routines, and been higher 
educated.  
2) The data was only collected from the three peri urban clinics outside Harare 
and not from other parts of the country. The study population would therefor 
be a selective part of the population, and might not be representative for the 
total population.  
 
- Measurement of weight, length and head circumference: The field activities were 
performed by trained midwives/nurses and laboratory people. The qualified personnel 
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team was trained for two weeks in study techniques, such as recruitment of the 
women, explanation of the study protocol, practical data collection etc. (27) 
The measurements are probably representing many sources of bias, even when 
performed systematically. Even though it is described that the nurses and midwives 
were trained, we do not know if the measurements were standardized or not. There 
can be errors according to the accuracy of the measurements, such as weight scales in 
gram or kilogram, stretching of the baby´s legs when measuring the length and 
standard measure technique for head circumference? Different persons were doing the 
measures, which can lead to different measurements due to different techniques. In 
the original study, there are only described that anthropometrical measurements were 
taken at each visit, but no further details about the methods. (27) Further, we have no 
information about the equipment used at the three clinics. Were they using same types 
of weight scales and measurement tapes? If different weight scales and measurement 
tapes were used, it can have led to significant sources of error, and we do not know 
whether the scales were calibrated regularly or not. However it is likely to believe that 
these measurement errors were equally divided in both study groups, and therefore it 
is possible that our findings are true.  
 
- Gestational age: The women were recruited in the study from gestational age 36, but 
we do not know which gestational age they gave birth, and therefore it is uncertain 
whether the HIV positive mothers gave birth to more prematurely babies. The more 
prematurely the infants are born, the more likely their weight and length is to be 
affected.  And how sure was the determination of gestational age in the first place? If 
a lot of the age determinations were wrong, surely this could alter the actual values.  
 
- HIV-status: A confirmatory HIV test was done on all women, regardless of their 
national HIV test result. The HIV results that were discrepant, false negative and false 
positive were retested using an ELISA-test. HIV-exposed children were screened for 
HIV using DNA-PCR up to 9 months of age. Cord blood was collected at birth, and 
venous blood was collected at the other visits, for HIV-DNA PCR analyses. (27) 
HIV-DNA PCR analyses are the standardised tests used for children < 18 months of 
age. The test has a 55% sensitivity at birth, increasing to >90 % by 2 to 4 weeks of 
age and 100% at 3 and 6 months. The specificity is 99.8 % at birth and 100 % at 1, 3, 
and 6 months. (29)  
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In the original study, HIV positive mothers received a single dose of Nevirapine, 200 
mg, to be taken at the onset of labour to reduce the risk of MTCT of HIV. Their 
infants received a single dose of Nevirapine, 1-2 mg, within 72 hours after delivery. 
How much did this reduce the number of infants born with HIV? And as a result of 
this, could that have affected the infants´ growth after birth? (27) 
 
We did not have any information about the stage of the mothers´ HIV-disease. Could 
the stage of disease affect the intrauterine growth and thereby the birth measurements? 
If there were more women in an early HIV-stage, could this be the reason for no 
statistically significant difference in growth according to maternal HIV-status? 
Compared to WHO data, our data were pretty much similar at birth, which could 
indicate that these women were not heavily affected or that the care for these women 
was better than expected.  
 
- Attendance: The follow-up consultations were scheduled at 6 weeks, 4 months and 9 
months after birth. After a year, follow-up was every 6 months for 5 years.  
As can be seen from table 10, 52.7 % of the HIV negative and 53.3 % of the HIV 
positive mothers attended more than 3 visits during the follow-up period. Only a few 
attended all the follow-up visits during the 5 years. Different reasons for not showing 
up at all the follow-up visits could be: transport difficulties, residence far from the 
clinics, sudden illness, ”no need” for it because the child seemed well or forgot to 
meet. 
 
- Criteria of inclusion and exclusion: We excluded the children with missing 
information about weight, length or head circumference at birth. We also excluded 
children without known gender and HIV-status and mothers without known HIV-
status. We have not collected information that can say if there were any twins in our 
study population, and therefor we do not have exact numbers for this. Twins in general 
have a lower birth weight than single babies, but since we do not know how many 
there were in our study and how they were divided in the two groups, we do not know 
how this affect our results. But since twin births in general are low frequent, this is 
probably of no value 
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4.2 Results 
 
There were no differences in growth according to maternal HIV status in our analysis.  
 
Comparison of growth in the two groups 
Our analyses showed no statistically significant difference in the children’s growth according 
to maternal HIV-status (except for head circumference at 4 months of age for the girls). This 
could be due to the sources of bias discussed above or other reasons we will discuss below. 
There is also a possibility that the results we found are true, and that there were no differences 
in the two groups.  
 
- When analysing and comparing growth we only used those children with 
measurements recorded at all time points. This means that we did not register those 
infants who died during the first 9 months of life. Our findings show a threefold 
higher child mortality among infants born by HIV positive mothers compared to HIV 
negative mothers. Since these were missed in our analysis and there was a higher 
mortality among children of HIV positive mothers, there is a possibility that this 
could have affected our results.  
 
- Other studies show variable results. A study done in Burkina Faso in 1995-1996 
showed no difference of significance at birth. This study included 956 pairs of 
mothers and their children. (30) In a study material from BHAMC, including 1045 
mothers and their infants, there were significant lower birth weight and length in 
children born by HIV positive mothers, but no differences in birth head 
circumference. (31).  
 
- Health seeking behaviour: It is possible that the women who knew that they were HIV 
positive and agreed to be a part of this study, were more conscious about their 
children´s health and diseases, and therefor took action earlier by seeking help from 
the health services, which could have improved their children´s growth.  
 
- Time spent on information giving and advises: One can assume that HIV positive 
mothers received more thorough information and advices from health workers and the 
time spent on them were greater than for HIV negative women.  
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- Information on infant feeding: All women who were included in the study were 
informed about infant feeding. It is possible that HIV positive mothers in this study 
had a better knowledge about choosing the right nutrition for their children, than HIV 
positive mothers in general.   
 
Low birth weight 
 
We found that a higher proportion of children of HIV positive mothers had a low birth 
weight, a 3,2% difference. This difference was not significant. Because of possible 
measurement errors we cannot be sure if these results are reliable, but as described earlier, 
measurement errors were probably equally divided in both groups and as a result of this, our 
findings are still valuable. There might be a smaller or larger difference than the one we 
found. Unknown gestational week might also lead to possible errors.  
 
Other factors 
 
- Age: More of the women in the HIV positive group had an age > 20 years. It is 
uncertain if this is relevant for the child’s growth. 
 
- Education:  HIV negative mothers had a higher education level, but these differences 
were minor. A higher education makes it easier to utilise information and advise 
given on child nutrition, and this could again affect children’s growth. Even though 
differences according to maternal HIV status were low, it is possible that women who 
decided to join the study had a higher education than the population in general 
(including the HIV positive mothers); it could affect the nutrition given to their 
children, resulting in a better growth. 
 
- Marital status: More HIV negative women were married, while more HIV positive 
mothers were living alone. The women who were married might have had a higher 
income because of economic support from their husbands, which could lead to more 
money to spend on food. Still this does not seem to have had big effects on our 
findings. It is likely to think that women living in a marital relationship have a lower 
prevalence of HIV because of a single sexual partner/stabile sexual behaviour.  
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- Breastfeeding: The HIV positive mothers breastfed less than the HIV negative 
mothers at all time points. Were the WHO guidelines followed in these cases? Did the 
children who were not breastfed receive proper supplement and did the HIV positive 
women receive ARV intervention? The HIV positive mothers received a single dose 
of Nevirapine at the onset of labour, and their children received a single dose within 
72 hours after birth. This may have contributed to the fact that we did not find any 
statistical significant differences in growth between the to groups during the 9 months 
of follow-up. There is a possibility that true differences in growth would appear later. 
The data from the study period do not describe if the mothers and/or their infants 
received further essential treatment. No difference was found in child growth, but is it 
possible that children who were not breastfed could suffer from malnutrition, 
compared to those who were breastfed?  
 
- Follow-up visits with infant: There were no difference in follow-up visits in the two 
groups, but in general we could say that the follow-up rate was low, which could have 
affected other findings in this study. This is also described under the discussion of 
methods.  
 
- Deceased mother: As one could imagine, there were a higher proportion of deceased 
mothers in the HIV positive group. Could children of these mothers have a more 
affected growth? In that case, these children were lost in the follow-up, and thereby 
could have affected our results leading to a higher mean growth than the actual mean 
growth in the HIV positive mothers group. But since the numbers of deceased 
mothers were low, it is likely to think that this would marginally influence our results.  
 
- Deceased infant: A higher proportion of children of HIV positive mothers died in this 
study. Half of the deceased children in this group were HIV positive them selves, 
which in turn could explain a big part of the differences according to maternal HIV 
status. And if we divide the children of HIV positive mothers in to two groups 
according to their child´s HIV status we find that 5.9% of HIV negative children 
deceased, compared to 22.1 % in the HIV positive children.  
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5.0 CONCLUSION 
 
In our study we found no statistical significant differences in weight, length and head 
circumference according to maternal HIV-status the first 9 months of life for both genders.  
And neither did we find any significant differences in low birth weight. However these results 
may be questionable, because of a limited compliance on follow-up and uncertainty of 
measurements and skills of health workers. Still we believe our results are valuable since it is 
likely that measurement errors were equally divided, and that the follow-up frequency was 
similar in both the HIV positive and negative group. What we did find, was that HIV positive 
mothers had a higher mortality, and that the children of HIV positive mothers had a threefold 
higher mortality during the first 9 months of life. The child mortality differences in the two 
groups show that there is still a lot of work to be done to better the survival of children born 
of HIV positive mothers.  
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